Literature DB >> 16484547

Genistein, estrogen receptors, and the acquired immune response.

Paul S Cooke1, Vimal Selvaraj, Srikanth Yellayi.   

Abstract

Estrogen regulates thymic development and immune function. Despite the critical role of estrogens in inducing thymic involution and modulating immune responses, the mechanism of this effect is unclear. Similarly, humans and animals are exposed to increasing amounts of the estrogenic soy isoflavone genistein in the diet, but whether genistein can induce immune changes has not been definitively established. We reported previously that genistein induces thymic atrophy in mice, and decreases both humoral and cell-mediated immunity. These thymic effects of genistein occur via estrogen receptor (ER)-mediated and non-ER-mediated pathways. Genistein injections produced the most pronounced effects, but dietary administration to mice that produced serum genistein concentrations similar to those reported in human infants consuming soy formula also had demonstrable effects. Microarray analysis of the effects of estradiol and genistein on neonatal thymus indicated that estradiol affected genes involved in transcription, apoptosis, cell cycle, and thymic development and function; genistein had similar effects on many estradiol target genes, but also had unique actions not replicated by estradiol. Despite extensive work showing inhibitory effects of genistein on immunity, other rodent studies reported that genistein or other phytoestrogens stimulate various aspects of immune function. Although the present data strongly indicate that genistein can regulate immune function, possibly at physiologic concentrations, further work is required to definitively establish overall thymic and immune effects of genistein and soy, which may vary with age, species, and specific end point.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16484547     DOI: 10.1093/jn/136.3.704

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  20 in total

1.  Mutated Pathways as a Guide to Adjuvant Therapy Treatments for Breast Cancer.

Authors:  Yang Liu; Zhenjun Hu; Charles DeLisi
Journal:  Mol Cancer Ther       Date:  2015-12-01       Impact factor: 6.261

2.  Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced proinflammatory cytokines and immunosuppressive cells.

Authors:  Gregory B Lesinski; Patrick K Reville; Thomas A Mace; Gregory S Young; Jennifer Ahn-Jarvis; Jennifer Thomas-Ahner; Yael Vodovotz; Zeenath Ameen; Elizabeth Grainger; Kenneth Riedl; Steven Schwartz; Steven K Clinton
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

Review 3.  Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs.

Authors:  Adriana Albini; Stefano Indraccolo; Douglas M Noonan; Ulrich Pfeffer
Journal:  Clin Exp Metastasis       Date:  2010-04-10       Impact factor: 5.150

Review 4.  The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.

Authors:  Samantha N Freedman; Shailesh K Shahi; Ashutosh K Mangalam
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

5.  The effects of dietary levels of genistein on ovarian follicle number and gene expression.

Authors:  Payel Kundu; Shreya Patel; Daryl D Meling; Kassie Deal; Liying Gao; William G Helferich; Jodi A Flaws
Journal:  Reprod Toxicol       Date:  2018-07-26       Impact factor: 3.143

Review 6.  Regulation of the immune response by soybean isoflavones.

Authors:  Madhan Masilamani; John Wei; Hugh A Sampson
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

7.  Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat model.

Authors:  Anna Hsu; Richard S Bruno; Christiane V Löhr; Alan W Taylor; Rodrick H Dashwood; Tammy M Bray; Emily Ho
Journal:  J Nutr Biochem       Date:  2011-05       Impact factor: 6.048

8.  Soy isoflavone intake is associated with risk of Kawasaki disease.

Authors:  Michael A Portman; Sandi L Navarro; Margaret E Bruce; Johanna W Lampe
Journal:  Nutr Res       Date:  2016-04-12       Impact factor: 3.315

9.  FcγR gene copy number in Kawasaki disease and intravenous immunoglobulin treatment response.

Authors:  Robert Makowsky; Howard W Wiener; Travis S Ptacek; Miriam Silva; Aditi Shendre; Jeffrey C Edberg; Michael A Portman; Sadeep Shrestha
Journal:  Pharmacogenet Genomics       Date:  2013-09       Impact factor: 2.089

Review 10.  AHR-mediated immunomodulation: the role of altered gene transcription.

Authors:  Nancy I Kerkvliet
Journal:  Biochem Pharmacol       Date:  2008-11-27       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.